CDKN2A is involved in cell-cycle progression and has been validated to play an important role in many kinds of cancers, including pancreatic cancer (Gu et al., 2020), sebaceous gland carcinoma of the eyelid (Yunoki et al., 2020) and so on. Here, CDKN2A is linked to cancer.